Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, RNA modifications and cancer, and Lymphoma Diagnosis and Treatment.
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
mTOR Inhibition in the Management of Recurrent Metastatic Solid Pseudopapillary Tumor of the Pancreas.
Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping Lymphomas.
Aneuploidy sensitizes cells to SREBP-pathway inhibition in squamous cell carcinoma
Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.
Caspase 3 and caspase 7 promote cytoprotective autophagy and the DNA damage response during non-lethal stress conditions in human breast cancer cells.
Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm.
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis.
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.
The cost and cost trajectory of genome sequencing and bioinformatics analysis for Indigenous children with suspected rare diseases.
Cross-Platform Methylation-Based Site of Origin Classification for Squamous Cell Carcinomas.
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication.
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.
How structural variation shapes the cancer epigenome.
Non-Metastatic Pure Pancreatic Hepatoid Carcinoma with Genomic and Transcriptomic Analysis: A Case Report.
Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications.
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma.
Supplementary Tables from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Data from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Spatial and multi-omic profiling reveals genes and pathways associated with cytotoxic lymphocyte infiltration in malignant rhabdoid tumor
Supplementary Figures from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes.
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.
Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities.
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors.